Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon purchased 7,500 shares of the business’s stock in a transaction on Wednesday, May 22nd. The stock was purchased at an average cost of $2.63 per share, with a total value of $19,725.00. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
CVRS traded down $0.05 during mid-day trading on Friday, reaching $2.66. The stock had a trading volume of 965,692 shares, compared to its average volume of 1,161,391. Corindus Vascular Robotics Inc has a 52 week low of $0.70 and a 52 week high of $3.10.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its quarterly earnings results on Tuesday, May 7th. The medical equipment provider reported ($0.05) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.05). The company had revenue of $3.04 million during the quarter, compared to analyst estimates of $2.90 million.
Separately, Zacks Investment Research cut Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, May 14th.
A number of institutional investors have recently modified their holdings of CVRS. Jane Street Group LLC acquired a new stake in Corindus Vascular Robotics during the 4th quarter worth $36,000. HRT Financial LLC bought a new position in Corindus Vascular Robotics during the 4th quarter worth about $44,000. Canton Hathaway LLC bought a new position in Corindus Vascular Robotics during the 1st quarter worth about $63,000. Virtu Financial LLC bought a new position in Corindus Vascular Robotics during the 4th quarter worth about $64,000. Finally, Weiss Asset Management LP bought a new position in Corindus Vascular Robotics during the 1st quarter worth about $65,000.
COPYRIGHT VIOLATION WARNING: “Corindus Vascular Robotics Inc (CVRS) Director Louis A. Cannon Buys 7,500 Shares” was posted by Tech Know Bits and is the property of of Tech Know Bits. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://techknowbits.com/2019/06/01/louis-a-cannon-buys-7500-shares-of-corindus-vascular-robotics-inc-cvrs-stock.html.
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.
Read More: How do candlesticks reflect price movement?
Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.